Neutrophils and Angiogenesis: Potential Initiators of the Angiogenic Cascade

Chemical Immunology and Allergy

Volumn 83, Issue , 2003, Pages 167-181

  Benelli, Roberto ^a   Albini, Adriana ^a   Noonan, Douglas ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; ANTIINFLAMMATORY AGENT; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CYCLOOXYGENASE 2 INHIBITOR; FREE RADICAL; INTERLEUKIN 8; SCATTER FACTOR; THROMBOCYTE ACTIVATING FACTOR; VASCULOTROPIN; INTERLEUKIN 18;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CHEMOTAXIS; ENDOTHELIUM CELL; INFLAMMATION; INFLAMMATORY CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULARIZATION; ANIMAL; HUMAN; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FREE RADICALS; HUMANS; INTERLEUKIN-18; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; PLATELET ACTIVATING FACTOR; RECEPTORS, INTERLEUKIN-8B;

EID: 0141688295     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000071560     Document Type: Review

References (74)

1. Folkman J: Angiogenesis in arthritis; in Lipsky PE (ed): Biological Therapy in Rheumatology. London, Martin Dunitz, in press.
2. Coussens LM, Werb Z: Inflammatory cells and cancer: Think different! J Exp Med 2001;193: F23-F26.
3. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-1801.
4. Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ, Elner SG: Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 1992;141:1279-1284.
5. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL: Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 1995;57:752-762.
6. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, et al: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995;270:27348-27357.
7. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM: CXC chemokines in angiogenesis. J Leukoc Biol 2000;68:1-8.
8. Mirshahi F, Pourtau J, Li H, Muraine M, Trochon V, Legrand E, Vannier J, Soria J, Vasse M, Soria C: SDF-1 activity on microvascular endothelial cells: Consequences on angiogenesis in in vitro and in vivo models. Thromb Res 2000;99:587-594.
9. Borgstrom P, Discipio R, Maione TE: Recombinant platelet factor 4, an angiogenic marker for human breast carcinoma. Anticancer Res 1998;18:4035-4041.
10. Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ: Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun 1995;210:51-57.
11. Chen PW, Ksander BR: Immune privilege, tumors, and the eye. Chem Immunol 1999;73:137-158.
12. Streilein JW: Anterior chamber associated immune deviation: The privilege of immunity in the eye. Surv Ophthalmol 1990;35:67-73.
13. Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM: The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 2000;165:5269-5277.
14. Petzelbauer P, Watson CA, Pfau SE, Pober JS: IL-8 and angiogenesis: Evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995;7:267-272.
15. Schonbeck U, Brandt E, Petersen F, Flad HD, Loppnow H: IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995;154:2375-2383.
16. Benelli R, Morini M, Carrozzino F, Ferrari N, Minghelli S, Santi L, Cassatella M, Noonan DM, Albini A: Neutrophils as a key cellular target for angiostatin: Implications for regulation of angiogenesis and inflammation. FASEB J 2002;16:267-269.
17. Gillitzer R, Goebeler M: Chemokines in cutaneous wound healing. J Leukoc Biol 2001;69:513-521.
18. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M: Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 1996;93:6682-6686.
19. Gaudry M, Bregerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J: Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997;90:4153-4161.
20. Devalaraja RM, Nanney LB, Du J, Qian Q, Yu Y, Devalaraja MN, Richmond A: Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 2000;115:234-244.
21. McCourt M, Wang JH, Sookhai S, Redmond HP: Activated human neutrophils release hepatocyte growth factor/scatter factor. Eur J Surg Oncol 2001;27:396-403.
22. Betz SJ, Henson PM: Production and release of platelet-activating factor (PAF); dissociation from degranulation and superoxide production in the human neutrophil. J Immunol 1980;125:2756-2763.
23. Miyagawa H, Nabe M, Hopp RJ, Agrawal DK, Bewtra AK, Townley RG: Elevation of neutrophil chemotactic activity in the human serum and the decreased number of neutrophils after platelet-activating factor inhalation. Int Arch Allergy Appl Immunol 1990;92:199-202.
24. Swain SD, Bunger PL, Sipes KM, Nelson LK, Jutila KL, Boylan SM, Quinn MT: Platelet-activating factor induces a concentration-dependent spectrum of functional responses in bovine neutrophils. J Leukoc Biol 1998;64:817-827.
25. Camussi G, Montrucchio G, Lupia E, Arese M, Bussolino F: Platelet-activating factor and angiogenesis. Adv Exp Med Biol 1996;416:231-234.
26. Camussi G, Montrucchio G, Lupia E, De Martino A, Perona L, Arese M, Vercellone A, Toniolo A, Bussolino F: Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J Immunol 1995;154:6492-6501.
27. Montrucchio G, Lupia E, de Martino A, Battaglia E, Arese M, Tizzani A, Bussolino F, Camussi G: Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Am J Pathol 1997;151:557-563.
28. Jackson JR, Bolognese B, Mangar CA, Hubbard WC, Marshall LA, Winkler JD: The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. Biochim Biophys Acta 1998;1392:145-152.
29. Ko HM, Seo KH, Han SJ, Ahn KY, Choi IH, Koh GY, Lee HK, Ra MS, Im SY: Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. Cancer Res 2002;62:1809-1814.
30. Yamashiro S, Kamohara H, Yoshimura T: MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression. J Leukoc Biol 1999;65:671-679.
31. Ono M, Torisu H, Fukushi J, Nishie A, Kuwano M: Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother Pharmacol 1999;43:S69-S71.
32. Sunderkotter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C: Macrophage-derived angiogenesis factors. Pharmacol Ther 1991;51:195-216.
33. Crowther M, Brown NJ, Bishop ET, Lewis CE: Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 2001;70:478-490.
34. Kelly RW, Illingworth P, Baldie G, Leask R, Brouwer S, Calder AA: Progesterone control of interleukin-8 production in endometrium and chorio-decidual cells underlines the role of the neutrophil in menstruation and parturition. Hum Reprod 1994;9:253-258.
35. Mueller MD, Lebovic DI, Garrett E, Taylor RN: Neutrophils infiltrating the endometrium express vascular endothelial growth factor: Potential role in endometrial angiogenesis. Fertil Steril 2000;74:107-112.
36. Gargett CE, Rogers PA: Human endometrial angiogenesis. Reproduction 2001;121:181-186.
37. Gargett CE, Lederman F, Heryanto B, Gambino LS, Rogers PA: Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium. Role of intravascular neutrophils. Hum Reprod 2001;16:1065-1075.
38. Trenam CW, Dabbagh AJ, Morris CJ, Blake DR: Skin inflammation induced by reactive oxygen species (ROS): An in-vivo model. Br J Dermatol 1991;125:325-329.
39. Volk T, Hensel M, Schuster H, Kox WJ: Secretion of MCP-1 and IL-6 by cytokine stimulated production of reactive oxygen species in endothelial cells. Mol Cell Biochem 2000;206:105-112.
40. Irani K: Oxidant signaling in vascular cell growth, death, and survival: A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000;87:179-183.
41. Wedgwood S, Dettman RW, Black SM: ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 2001;281:L1058-L1067.
42. Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, Galeotti T: Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 2002;277:3101-3108.
43. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK: Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 2001;98:2604-2609.
44. Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R: Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002;39:135-141.
45. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
46. Soff GA: Angiostatin and angiostatin-related proteins. Cancer Metastasis Rev 2000;19:97-107.
47. Lucas R, Holmgren L, Garcia I, Jimenez B, Mandriota SJ, Borlat F, Sim BK, Wu Z, Grau GE, Shing Y, Soff GA, Bouck N, Pepper MS: Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 1998;92:4730-4741.
48. Chavakis E, Dimmeler S: Regulation of endothelial cell survival and apoptosis during angiogenesis. Arterioscler Thromb Vasc Biol 2002;22:887-893.
49. Scapini P, Nesi L, Morini M, Tanghetti E, Belleri M, Noonan D, Presta M, Albini A, Cassatella MA: Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J Immunol 2002;168:5798-5804.
50. Bliss SK, Marshall AJ, Zhang Y, Denkers EY: Human polymorphonuclear leukocytes produce IL-12, TNF-alpha, and the chemokines macrophage-inflammatory protein-1 alpha and -1 beta in response to Toxoplasma gondii antigens. J Immunol 1999;162:7369-7375.
51. Bliss SK, Butcher BA, Denkers EY: Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J Immunol 2000;165:4515-4521.
52. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA: The neutrophil as a cellular source of chemokines. Immunol Rev 2000;177:195-203.
53. Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G, Detheux M, Parmentier M, Durinx C, Lambeir AM, Neyts J, Liekens S, Maudgal PC, Billiau A, Van Damme J: Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 2001;98:3554-3561.
54. Masferrer J: Approach to angiogenesis inhibition based on cyclooxygenase-2. Cancer J 2001;7(suppl 3):S144-S150.
55. Fosslien E: Review: Molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 2001;31:325-348.
56. Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M: Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 1999;79:1469-1477.
57. Yanaga H, Fujii T, Koga T, Araki R, Shirouzu K: Prevention of carcinogenesis of mouse mammary epithelial cells RIII/MG by epigallocatechin gallate. Int J Mol Med 2002;10:311-315.
58. Zhang M, Binns CW, Lee AH: Tea consumption and ovarian cancer risk: A case-control study in China. Cancer Epidemiol Biomarkers Prev 2002;11:713-718.
59. Hsu SD, Singh BB, Lewis JB, Borke JL, Dickinson DP, Drake L, Caughman GB, Schuster GS: Chemoprevention of oral cancer by green tea. Gen Dent 2002;50:140-146.
60. Cao Y, Cao R: Angiogenesis inhibited by drinking tea. Nature 1999;398:381.
61. Das M, Sur P, Gomes A, Vedasiromoni JR, Ganguly DK: Inhibition of tumour growth and inflammation by consumption of tea. Phytother Res 2002;16(suppl 1):S40-S44.
62. Sartor L, Pezzato E, Garbisa S: (-)Epigallocatechin-3-gallate inhibits leukocyte elastase: Potential of the phyto-factor in hindering inflammation, emphysema, and invasion. J Leukoc Biol 2002;71:73-79.
63. Van Dyke K, McConnell P, Marquardt L: Green tea extract and its polyphenols markedly inhibit luminol-dependent chemiluminescence activated by peroxynitrite or SIN-1. Luminescence 2000;15:37-43.
64. Hofbauer R, Frass M, Gmeiner B, Handler S, Speiser W, Kapiotis S: The green tea extract epigallocatechin gallate is able to reduce neutrophil transmigration through monolayers of endothelial cells. Wien Klin Wochenschr 1999;111:278-282.
65. Vene R, Benelli R, Noonan DM, Albini A: HIV-Tat dependent chemotaxis and invasion, key aspects of tat mediated pathogenesis. Clin Exp Metastasis 2000;18:533-538.
66. Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, Primo L, Noonan D, Salio M, Camussi G, Rockl W, Bussolino F: The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med 1996;2:1371-1375.
67. Albini A, Ferrini S, Benelli R, Sforzini S, Giunciuglio D, Aluigi MG, Proudfoot AE, Alouani S, Wells TN, Mariani G, Rabin RL, Farber JM, Noonan DM: HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci USA 1998;95:13153-13158.
68. Albini A, Benelli R, Giunciuglio D, Cai T, Mariani G, Ferrini S, Noonan DM: Identification of a novel domain of HIV tat involved in monocyte chemotaxis. J Biol Chem 1998;273:15895-15900.
69. Benelli R, Barbero A, Ferrini S, Scapini P, Cassatella M, Bussolino F, Tacchetti C, Noonan DM, Albini A: Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: Implications for Tat-mediated pathogenesis. J Infect Dis 2000;182:1643-1651.
70. Albini A, Fontanini G, Masiello L, Tacchetti C, Bigini D, Luzzi P, Noonan DM, Stetler-Stevenson WG: Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: Inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. Aids 1994;8:1237-1244.
71. Li Y, Karlin A, Loike JD, Silverstein SC: A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc Natl Acad Sci USA 2002;99:8289-8294.
72. Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow? Lancet 2001;357:539-545.
73. Brigati C, Noonan DM, Albini A, Benelli R: Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 2002;19:247-258.
74. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002;420:860-867.